openPR Logo
Press release

Colorectal Cancer Market is Expected to Generate Huge Profits by 2024

12-08-2017 12:33 PM CET | Health & Medicine

Press release from: Transparency Market Research

Colorectal Cancer Market is Expected to Generate Huge Profits

The World Cancer Research Fund International establishes that colorectal cancer is the third most common cancer in the world and in 2012 alone, an estimated 1.4 mn new cases were diagnosed. Of these, 54% cases were reported in developed countries. This growing incidence is the primary factor fueling the global colorectal cancer market, especially in the field of diagnostics, therapeutics, and treatment.

While the number of new colorectal cancer cases has been increasing year by year, the death rate from the same has been on a decline among women as well as men. The American Cancer Society pegs increased awareness among people and the development of new screening methods and more effective treatments as the most likely reasons for this. With a greater sense of awareness about colorectal cancer comes growing willingness toward early screening and diagnosis. This has had a positive impact on the overall colorectal cancer market.

Request for TOC @

The report is a comprehensive database of information pertaining to the drivers, restraints, and opportunities defining the global colorectal cancer market. A detailed analysis of the current market dynamics, the latest innovations, business strategies of leading players, and recent events in the industry has been provided in the report for the period 2016 to 2024.

Colorectal Cancer Market: Trends and Opportunities

The global colorectal cancer market is fueled by a number of factors, the primary one being high incidence of this disorder across emerging as well as developed regions. Apart from this, a massive aging population, the introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations around the world to improve the level of awareness among patients and develop more efficacious therapeutics. A high unmet need in several emerging economies and a lack of adjuvant and neoadjuvant pipeline agents to treat high-risk patients with resectable colorectal cancer represents a lucrative avenue for players in this market.

In contrast, however, factors such as the reluctance toward colorectal cancer medications on the part of patients and a certain lack of awareness in many parts of the world will pose a threat to the growth of the overall market.

Request for Brochure @

Colorectal Cancer Market: Regional Outlook

Geographically segmenting the global colorectal cancer market, the report covers four main segments: Asia Pacific, North America, Europe, and Rest of the World. North America is a key region in the market and accounts for a considerable share in terms of demand and revenue. This market is fueled by a number of factors, the primary one being greater prevalence of colorectal cancer. Based on estimates by the American Cancer Society, in 2017, 39,910 new rectal cancer cases and 95,520 new colon cancer cases will be reported in the U.S. In addition, an approximate 50,260 deaths resulting from colorectal cancer will be report this year. The North America colorectal cancer market is also driven by improved awareness about early detection, diagnosis, and screening, greater investments in research and development, the presence of leading drug and therapeutic companies, sophisticated healthcare infrastructure, and favorable reimbursement policies.

Developing countries are fast emerging as major markets for colorectal cancer thanks to improving healthcare facilities and rising expenditure of preventive healthcare. Asia Pacific, as a result, is poised for strong growth in the coming years, with China and India making rapid progress.

Pre Book full report@

Companies mentioned in the research report

F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Taiho Pharmaceutical, Eli Lilly and Company, and Pfizer, Inc. are presently the most promising companies operating in the global colorectal cancer market. The nature of the vendor landscape is immensely competitive with multinational companies establishing a strong hold over the rest. These players have been focused on devising successful strategies, such as competent marketing, expansion of geographical reach, prudent pricing, high investment in R&D, and offering clinical laboratory services. Product innovation is also viewed as one of the major growth strategies adopted by companies to gain a stronger foothold in the colorectal cancer market.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
TMR Blog:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Market is Expected to Generate Huge Profits by 2024 here

News-ID: 852086 • Views: 171

More Releases from Transparency Market Research

Endoscopy Repair MarketSet for Rapid Growth and Trend, by 2025
Global Endoscope Repair Market: Overview An endoscope is an instrument used to view any internal cavity of the human body. Endoscopes are inserted into the body via one of many natural orifices. A high resolution camera at the end of inert tubing allows visualization of the body from inside and makes clinical decision making easier. Endoscopes are made of inert material like polyurethane which resists corrosion from bodily fluids and is
Nasal Oxygen Cannula Marketto Set Phenomenal Growth by 2026
Global Nasal Oxygen Cannula Market: Overview A cannula is any tube inserted into the body. A nasal cannula is an oxygen conduit used to deliver high concentrations of oxygen to patients through the nose. Traditionally made of rubber, current versions are made of plastic and can be connected to any oxygen supply by a pliable universal connector. This allows easy adaptability of this product to any setting, for in patient or
Medically Supervised Weight Loss Service MarketShares, Strategies, and Forecasts …
Global Medically Supervised Weight Loss Service Market: Overview Obesity has reached concerning levels around the world, with an increasing number of people tipping the scales. 69% of Americans are estimated to be overweight or obese at this point in time. Excess weight is increasingly linked with a number of chronic diseases that figure as the top causes of mortality worldwide. Also, popular human aesthetics are pushing people towards a fitter body
Bone Conduction Hearing Devices Market: Business Overview and Global Development …
Global Bone Conduction Hearing Devices Market: Snapshot Growing instances of hearing issues among older population is working as a driving factor for the growth of the global bone conduction hearing devices market. Bone conduction hearing devices are gaining popularity in all worldwide populace owing to their ability to work as a substitute to conventional hearing devices. These devices are used by people who are suffering from hearing issues related to miss

All 5 Releases

More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and